Trulieve Cannabis Corp. reiterated earnings guidance for 2022 and provided earnings guidance for the second half of 2022. Trulieve is reiterating 2022 guidance with expected revenue in the range of $1.3 billion to $1.4 billion and adjusted EBITDA in the range of $450 million to $500 million. As the company has previously signaled, the company anticipates non-linear growth throughout 2022. The company expects transaction and integration-related charges will continue to impact reported EPS throughout 2022, with expected improvement, as the year progresses.

Based on the Company's current forecasts, it expects to realize improved performance in the second half of 2022 relative to the first half of 2022.

Following strong performance in March, the company anticipates second quarter 2022 revenue will be relatively flat compared to the first quarter 2022.